A New Tool for Helping Labs Improve Diversity in Clinical Trials
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
Rachel Rangel, AuD, discusses a new toolkit to help laboratory professionals ensure diversity and inclusion is addressed in their research.
However, the increase still isn’t enough to keep pace with inflation, providers contend.
While likely not a surprise to medical labs, a new report may add more urgency to solving recruitment and retention issues.
We’re inviting our readers to share their ideas for topics and presenters, both for future standalone webinars and our virtual events.
The Final Rule caps future PAMA cuts at 15 percent per calendar year.
A California health system will pony up $13 million to settle reference lab billing fraud claims.
In response to the latest data on repeat testing, on Nov. 1, the agency made a few changes to EUAs for such tests.
A doctor settles alleged FCA violations involving genetic tests, while a clinical lab owner pleads guilty for his role in another scheme.
Mobile phlebotomist services have become a dynamic new segment of the medical labs market.
Learn about the current state of the No Surprises Act, challenges in compliance, and how to navigate the law.
Medicare Administrative Contractors are shortchanging labs on monkeypox test reimbursement, association says.